Latest news
Emcure Pharma receives USFDA EIR for Sanand facility; regulator classifies it as 'VAI'; here's what it means - CNBC TV18CNBC TV18 · Sat, 08 Aug 2026 08:11:51 GMTCipla's InvaGen Receives USFDA EIR for New York Manufacturing Facility - Medical DialoguesMedical Dialogues · Tue, 04 Aug 2026 13:30:23 GMTCipla Gets USFDA Inspection Closure for InvaGen Plant - HDFC SkyHDFC Sky · Tue, 04 Aug 2026 04:45:00 GMTCipla Receives USFDA Approval Confirmation for InvaGen's New York Manufacturing Facility - SahiSahi · Tue, 04 Aug 2026 03:55:30 GMTZydus Receives USFDA EIR with VAI Status for Ahmedabad Injectable Facility - Medical DialoguesMedical Dialogues · Mon, 03 Aug 2026 13:35:47 GMTZydus Lifesciences shares in focus on EIR from USFDA; board meet on Aug 11 - Moneycontrol.comMoneycontrol.com · Mon, 03 Aug 2026 02:03:02 GMTZydus Lifesciences Receives USFDA EIR For Ahmedabad Injectable Facility With VAI Classification - SahiSahi · Sat, 01 Aug 2026 11:14:51 GMT